Medicamen Biotech Ltd Quarterly Results

Gross Sales

29.61

45.14

44.74

43.05

47.32

Excise Duty

0

0

0

0

0

Net Sales

29.61

45.14

44.74

43.05

47.32

Other Operating Income

0

0

0

0

0

Other Income

5.23

0.14

0.29

0.59

0.57

Total Income

34.84

45.28

45.03

43.63

47.89

Total Expenditure

31.22

38.44

39.43

39.6

41.57

PBIDT

3.62

6.85

5.6

4.03

6.32

Interest

0.65

0.76

1.04

0.71

1.89

PBDT

2.97

6.09

4.56

3.33

4.43

Depreciation

0.48

2.21

2.61

1.77

1.77

Minority Interest Before NP

0

0

0

0

0

Tax

0.73

1.03

1.05

0.84

0.79

Deferred Tax

-0.1

-0.07

0

-0.08

-0.18

Reported Profit After Tax

1.86

2.92

0.9

0.8

2.04

Minority Interest After NP

-0.55

-0.55

-0.55

-0.55

-0.09

Net Profit after Minority Interest

2.42

3.47

1.46

1.35

2.13

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

2.42

3.47

1.46

1.35

2.13

EPS (Unit Curr.)

1.47

2.3

0.71

0.63

1.61

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.71

12.71

12.71

12.71

12.71

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

12.22

15.17

12.51

9.36

13.35

PBDTM(%)

10.03

13.49

10.19

7.73

9.36

PATM(%)

6.28

6.46

2.01

1.85

4.31